Of note, radiotherapy strongly affected CTC count, causing their drastic decrease in twenty-four metastatic prostate cancer patients, while a CXCR4+ subpopulation of CTCs still persists up to three months upon treatment, suggesting their resistance to local radiotherapy [84,85,102]. The gene discussed is CXCR4; the disease is prostate carcinoma.